1. Bea, A M, Franco-Marín, E, Marco-Benedí, V, Civeira, F, Lamiquiz-Moneo, I. 2021. ANGPTL3 gene variants in subjects with familial combined hyperlipidemia. In Scientific reports, 11, 7002. doi:10.1038/s41598-021-86384-y. https://pubmed.ncbi.nlm.nih.gov/33772079/
2. Qiu, Min, Glass, Zachary, Chen, Jinjin, Zhang, Feng, Xu, Qiaobing. . Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3. In Proceedings of the National Academy of Sciences of the United States of America, 118, . doi:10.1073/pnas.2020401118. https://pubmed.ncbi.nlm.nih.gov/33649229/
3. Dewey, Frederick E, Gusarova, Viktoria, Dunbar, Richard L, Gromada, Jesper, Baras, Aris. 2017. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease. In The New England journal of medicine, 377, 211-221. doi:10.1056/NEJMoa1612790. https://pubmed.ncbi.nlm.nih.gov/28538136/
4. Zhang, Yuejie, Yan, Cen, Dong, Yuan, Sun, Fenghui, Feng, Yingmei. 2024. ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1 macrophage activation in plaque. In Journal of advanced research, , . doi:10.1016/j.jare.2024.05.011. https://pubmed.ncbi.nlm.nih.gov/38740260/
5. Raal, Frederick J, Rosenson, Robert S, Reeskamp, Laurens F, Zhang, Yi, Gaudet, Daniel. . Evinacumab for Homozygous Familial Hypercholesterolemia. In The New England journal of medicine, 383, 711-720. doi:10.1056/NEJMoa2004215. https://pubmed.ncbi.nlm.nih.gov/32813947/
6. Athyros, Vasilios G, Katsiki, Niki, Dimakopoulou, Aikaterini, Alataki, Sofia, Doumas, Michael. . Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation. In Current pharmaceutical design, 24, 3638-3646. doi:10.2174/1381612824666181009100517. https://pubmed.ncbi.nlm.nih.gov/30306859/
7. Brandts, Julia, Ray, Kausik K. . Familial Hypercholesterolemia: JACC Focus Seminar 4/4. In Journal of the American College of Cardiology, 78, 1831-1843. doi:10.1016/j.jacc.2021.09.004. https://pubmed.ncbi.nlm.nih.gov/34711342/
8. Michaeli, Daniel Tobias, Michaeli, Julia Caroline, Albers, Sebastian, Boch, Tobias, Michaeli, Thomas. 2023. Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention. In American journal of cardiovascular drugs : drugs, devices, and other interventions, 23, 477-495. doi:10.1007/s40256-023-00594-5. https://pubmed.ncbi.nlm.nih.gov/37486464/
9. Bini, Simone, Tramontano, Daniele, Minicocci, Ilenia, D'Erasmo, Laura, Arca, Marcello. 2023. How ANGPTL3 Inhibition Will Help Our Clinical Practice? In Current atherosclerosis reports, 25, 19-29. doi:10.1007/s11883-022-01076-w. https://pubmed.ncbi.nlm.nih.gov/36607583/
智鼠故事 
